Skip to main content
JW PHARMACEUTICAL logo

JW PHARMACEUTICAL — Investor Relations & Filings

Ticker · 001060 ISIN · KR7001060003 KO Manufacturing
Open in API
Filings indexed 310 across all filing types
Latest filing 2021-11-10 Earnings Release
Country KR South Korea
Listing KO 001060

About JW PHARMACEUTICAL

https://www.jw-pharma.co.kr/pharma/en/m…

JW Pharmaceutical is a company focused on the research, development, and commercialization of pharmaceutical products. It provides a broad portfolio of therapeutic drugs, including specialty medicines and over-the-counter (OTC) solutions. Key product areas include nutritional infusions (Combiflex®, Winuf®), treatments for neutropenia (Neutrogin®), and cardiovascular medicines (Livalo®). Its consumer healthcare offerings feature the Hi-mom® brand of advanced wound care products. The company emphasizes innovation, advancing a pipeline of new drugs targeting oncology and immune diseases. This research is driven by proprietary technology platforms and includes candidates such as the gout treatment Epaminurad.

Recent filings

Filing Released Lang Actions
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for JW Pharmaceutical, detailing quarterly financial highlights such as revenue, operating profit, and net income. It is a short, structured announcement of financial results rather than a full annual or interim report. According to the filing definitions, this fits the 'Earnings Release' (ER) category. Q3 2021
2021-11-10 Korean
채무인수결정
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from JW Pharmaceutical regarding a 'Debt Assumption Decision' (채무인수결정). It details the company's commitment to assume debt for its subsidiary, JW Medical, under specific conditions. This type of corporate disclosure regarding financial obligations and capital structure changes does not fit into specific categories like earnings releases or annual reports, and is best classified as a general regulatory filing.
2021-10-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed by the National Pension Service (국민연금공단) regarding their stake in JW Pharmaceutical (JW중외제약). This type of filing is a standard regulatory requirement for institutional investors when their shareholding crosses specific thresholds (typically 5%). In the provided classification schema, this falls under 'Major Shareholding Notification'.
2021-10-06 Korean
채무인수결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Debt Assumption Decision' (채무인수결정) by JW Pharmaceutical. It details the financial commitment, the relationship between the entities, and the board's resolution date. Since this is a specific corporate financial event involving debt obligations and financing arrangements that does not fit into the other specialized categories like M&A or share issues, it is classified as a general regulatory filing.
2021-10-01 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for JW Pharmaceutical, covering the period from January 1, 2021, to June 30, 2021. It contains comprehensive financial information, including financial statements, notes, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
공정거래자율준수프로그램운영현황(안내공시)
Governance Information Classification · 100% confidence The document is a regulatory filing from JW Pharmaceutical regarding their 'Compliance Program' (CP) operational status. It details the performance of the first half of 2021 and the plan for the second half of 2021. This type of disclosure, which provides information on internal governance, compliance, and ethical management practices, falls under the category of Governance Information (CGR) as it details the company's internal rules and compliance structure.
2021-08-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.